The Role of Milk Derived Peptides on Glycaemic Control

NCT03102463 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 6

Last updated 2017-08-14

No results posted yet for this study

Summary

This study aims to ascertain the potential of novel milk derived hydrolysates to improve glycaemic control to promote metabolic health. A comprehensive characterisation of the metabolic response to these milk derived hydrolysates will ascertain the effect of the hydrolysates in terms of insulin sensitivity. These hydrolysates have been shown to improve insulin resistance in cell and animal models. Therefore the investigators aim is to test their efficacy in overweight, insulin resistant individuals at risk of developing type 2 diabetes.

Conditions

Interventions

DIETARY_SUPPLEMENT

Water Control

120mL water given as a control, followed by a hyperinsulinemic-euglycaemic clamp

DIETARY_SUPPLEMENT

Milk derived hydrolysate

Milk derived hydrolysate made up as a milkshake in 120mL water, followed by a hyperinsulinemic-euglycaemic clamp

DIETARY_SUPPLEMENT

Parent Protein

Parent protein made up as a milkshake in 120mL water, followed by a hyperinsulinemic-euglycaemic clamp

OTHER

Lipid Load

100mL oral lipid load

Sponsors & Collaborators

  • Enterprise Ireland

    collaborator OTHER_GOV
  • University College Dublin

    lead OTHER

Principal Investigators

  • Helen M Roche, PhD · University College Dublin

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-10-31
Primary Completion
2017-06-30
Completion
2017-06-30

Countries

  • Ireland

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03102463 on ClinicalTrials.gov